Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: The University of Florida experience

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 3, 2005, Pages 310-316

  Zlotecki, Robert A ^a,b   Katz, Teri S ^a   Morris, Christopher G ^a   Scott Lind, D ^a   Hochwald, Steven N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Adjuvant radiotherapy; Retroperitoneal neoplasms; Soft tissue neoplasms; Treatment outcome

Indexed keywords

ABDOMINAL ABSCESS; ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DIARRHEA; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE OBSTRUCTION; LUNG EMBOLISM; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RETROPERITONEAL HEMORRHAGE; RETROPERITONEAL SARCOMA; SEPSIS; SOFT TISSUE SARCOMA; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FLORIDA; HUMANS; IRIDIUM RADIOISOTOPES; LIFE TABLES; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, HIGH-ENERGY; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 20444397352     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000158441.96455.31     Document Type: Article

References (44)

1. Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg. 1991;214:2-10.
2. Clark JA, Tepper JE. Role of radiation therapy in retroperitoneal sarcomas. Oncology (Huntingt). 1996;10:1867-1872.
3. Dalton RR, Donohue JH, Mucha P Jr, et al. Management of retroperitoneal sarcomas. Surgery. 1989;106:725-732.
4. Karakousis CP, Velez AF, Gerstenbluth R, et al. Resectability and survival in retroperitoneal sarcomas. Ann Surg Oncol. 1996;3:150-158.
5. Catton CN, O'Sullivan B, Kotwall C, et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1994;29:1005-1010.
6. Bevilacqua RG, Rogatko A, Hajdu SI, et al. Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Arch Surg. 1991;126:328-334.
7. Heslin MJ, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol. 1997;15:2832-2839.
8. Jaques DP, Coit DG, Hajdu SI, et al. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg. 1990; 212:51-59.
9. Karakousis CP, Velez AF, Emrich LJ. Management of retroperitoneal sarcomas and patient survival. Am J Surg. 1985;150:376-380.
10. Alvarenga JC, Ball AB, Fisher C, et al. Limitations of surgery in the treatment of retroperitoneal sarcoma. Br J Surg. 1991;78:912-916.
11. Karakousis CP, Gerstenbluth R, Kontzoglou K, et al. Retroperitoneal sarcomas and their management. Arch Surg. 1995;130:1104-1109.
12. Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355-365.
13. Glenn J, Sindelar WF, Kinsella T, et al. Results of multimodality therapy or resectable soft-tissue sarcomas of the retroperitoneum. Surgery. 1985;97:316-325.
14. Mäkelä J, Kiviniemi H, Laitinen S. Prognostic factors predicting survival in the treatment of retroperitoneal sarcoma. Eur J Surg Oncol. 2000;26:552-555.
15. Hassen I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg. 2004;239:244-250.
16. Pisters PW, Ballo MT, Fenstermacher MJ, et al. Phase 1 trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003;21:3092-3097.
17. Pirayesh A, Chee Y, Helliwell TR, et al. The management of retroperitoneal soft tissue sarcoma: a single institution experience with a review of the literature. Eur J Surg Oncol. 2001;27:491-497.
18. Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92: 359-368.
19. Bose B. Primary malignant retroperitoneal tumours: analysis of 30 cases. Can J Surg. 1979;22:215-220.
20. Cody HS III, Turnbull AD, Fortner JG, et al. The continuing challenge of retroperitoneal sarcomas. Cancer. 1981;47:2147-2152.
21. Harrison LB, Gutierrez E, Fisher JJ. Retroperitoneal sarcomas: the Yale experience and a review of the literature. J Surg Oncol. 1986;32:159-164.
22. Wist E, Solheim OP, Jacobsen AB, et al. Primary retroperitoneal sarcomas. A review of 36 cases. Acta Radiol Oncol. 1985;24:305-310.
23. Tepper JE, Suit HD, Wood WC, et al. Radiation therapy of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 1984;10:825-830.
24. Fein DA, Corn BW, Lanciano RM, et al. Management of retroperitoneal sarcomas: does dose escalation impact on locoregional control? Int J Radiat Oncol Biol Phys. 1995;31:129-134.
25. Gilbeau L, Kantor G, Stoeckle E, et al. Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother Oncol. 2002;65:137-143.
26. Youssef E, Fontanesi J, Mott M, et al. Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors. Int J Radiat Oncol Biol Phys. 2002;54: 514-519.
27. Jones JJ, Catton CN, O'Sullivan B, et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol. 2002;9:346-354.
28. Petersen IA, Haddock MG, Donohue JH, et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2002;52:469-475.
29. Willett CG. Intraoperative radiation therapy. Int J Clin Oncol. 2001;6: 209-214.
30. Gunderson LL, Nagorney DM, Mcllrath DC, et al. External beam and intraoperative electron irradiation for locally advanced soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 1993;25:647-656.
31. Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg. 1993;128:402-410.
32. Alektiar KM, Hu K, Anderson L, et al. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 2000;47:157-163.
33. Harrison LB, Minsky BD, Enker WE, et al. High-dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1998;42:325-330.
34. Gieschen HL, Spiro IJ, Suit HD, et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2001;50:127-131.
35. Pisters PW, O'Sullivan B. Retroperitoneal sarcomas: combined modality treatment approaches. Curr Opin Oncol. 2002;14:400-405.
36. Pisters PW, Ballo MT, Patel SR. Preoperative chemoradiation treatment strategies for localized sarcoma [review]. Ann Surg Oncol. 2002;9:535-542.
37. Demetri GD, Delaney T, NCCN Sarcoma Practice Guidelines Panel. NCCN: sarcoma [review]. Cancer Control. 2001;8:94-101.
38. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1980;153:106-120.
39. SAS Institute Inc. SAS OnlineDoc®, Version 8. Cary, NC: SAS Institute; 1999.
40. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
41. Cox DR. Regression models and life tables-series B (methodological). J R Stat Soc. 1972;34:187-220.
42. Kilkenny JW III, Bland KI, Copeland EM III. Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg. 1996;182:329-339.
43. Shaw EG, Gunderson LL, Martin JK, et al. Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis. Radiother Oncol. 1990;18:247-255.
44. Fiveash JB, Hyatt MD, Caranto J, et al. Preoperative IMRT with dose escalation to tumor subvolumes for retroperitoneal sarcomas: initial clinical results and potential for future dose escalation [abstract]. Int J Radiat Oncol Biol Phys. 2002;54:140.